RESULTS
Of the 61 patients who received at least one dose of remdesivir, data from 8 could not be analyzed (including 7 patients with no post-treatment data and 1 with a dosing error). Of the 53 patients whose data were analyzed, 22 were in the United States, 22 in Europe or Canada, and 9 in Japan. At baseline, 30 patients (57%) were receiving mechanical ventilation and 4 (8%) were receiving extracorporeal membrane oxygenation. During a median follow-up of 18 days, 36 patients (68%) had an improvement in oxygen-support class, including 17 of 30 patients (57%) receiving mechanical ventilation who were extubated. A total of 25 patients (47%) were discharged, and 7 patients (13%) died; mortality was 18% (6 of 34) among patients receiving invasive ventilation and 5% (1 of 19) among those not receiving invasive ventilation. CONCLUSIONS
In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). Measurement of efficacy will require ongoing randomized, placebo-controlled trials of remdesivir therapy. (Funded by Gilead Sciences.)
随便看看
- 不是咳嗽!Delta病毒新5大症状曝光 第1名超意外
- 社区负责人惊爆:小区一天死6人 武汉800社区 医护人员: 武汉死10万正常
- 不抽烟、不喝酒,为什幺得癌症的偏偏是我?医生说出了大实话
- 正式追查谭赛徳本人,限期4月27日!美国国会正式
- 医生真实病例讲述:乳房按摩,坑害了多少无辜女性
- 重要的事情讲三遍:一定要重视室内外的空气污染!
- 河北疫情跨省传至山西 晋中进入战时状态
- 1天新增近35万印度变人间炼狱,加拿大宣布援助
- 中医养生知识大全100条
- 党媒再次证实本人新疆疫情预报
- 马来西亚发现了新冠病毒新突变种,会让现有疫苗研究失效吗?
- 肾不好是吃出来?提醒:3种食物别多吃(组图)
- 阎丽梦:他们会只造一个病毒株吗? 下次...
- 人吃狗药,为什幺??
- 【营养与食品】减肥不吃草,专家教你科学健康减肥餐
- 日常养生 从脚部做起